+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Oncology Molecular Diagnostics Global Market Report 2024

  • PDF Icon

    Report

  • 250 Pages
  • February 2024
  • Region: Global
  • The Business Research Company
  • ID: 5733766
The oncology molecular diagnostics market size has grown rapidly in recent years. It will grow from $4.19 billion in 2023 to $4.84 billion in 2024 at a compound annual growth rate (CAGR) of 15.6%. The growth observed in the historic period can be credited to the introduction of early tests in the market, advancements in genomic profiling, the inception of next-generation sequencing (NGS), early identification of biomarkers, and the development of targeted therapies.

The oncology molecular diagnostics market size is expected to see rapid growth in the next few years. It will grow to $7.99 billion in 2028 at a compound annual growth rate (CAGR) of 13.3%. The anticipated growth in the forecast period can be ascribed to progress in liquid biopsy techniques, the emergence of companion diagnostics, the incorporation of artificial intelligence (AI), the broadening applications of next-generation sequencing (NGS), and the ongoing evolution in biomarker identification. Major trends expected in the forecast period encompass increased global accessibility, ongoing efforts in biomarker discovery and validation, refinement of regulatory frameworks, enhancements in technological platforms, and the promotion of patient-centric care models.

The increase in the global number of cancer cases is poised to contribute to the expansion of the oncology molecular diagnostics market. In 2021, the USA witnessed 1.8 million new cases and 0.6 million cancer-related deaths, as reported by the American Cancer Society. The most prevalent cancer types worldwide - lung, prostate, bowel, and female breast cancer - accounted for 43% of all new cancer cases. Consequently, the surge in global cancer incidence rates is expected to drive demand for the oncology molecular diagnostics market in the coming years.

The growing preference for personalized medicine is anticipated to fuel the future growth of the oncology molecular diagnostics market. Personalized medicine represents an innovative medical treatment approach that tailors decisions, practices, interventions, and drug therapies to individual patients. In the realm of cancer care, oncology molecular diagnostics play a crucial role in delivering personalized treatment plans, optimizing drug selection, and implementing more precise, effective, and individualized treatment strategies. This approach ultimately enhances patient outcomes and improves the overall quality of life. As of October 2022, reports from the US-based health news company STAT indicated that there were over 75,000 genetic testing products and 300 personalized medicines. Hence, the rising demand for personalized medicine is a driving force behind the growth of the oncology molecular diagnostics market.

The substantial cost associated with molecular diagnostic tests poses a significant challenge to the oncology molecular diagnostics market. Molecular diagnostic testing in cancer care tends to be comparatively expensive, and the costs vary depending on the type of therapy. For instance, the molecular diagnostic test cost for non-small cell lung cancer monotherapy ranges from $10,000 to $20,000 per month, with further increases expected for combination therapies. Consequently, the high cost of molecular diagnostic tests is anticipated to impede the growth of the oncology molecular diagnostics market.

An important trend in the oncology molecular diagnostics market is the adoption of advanced genomics technology. Continuous progress in cancer genome sequencing technology, computational analysis, tumor modeling, and the introduction of modern research methods in cancer studies contribute to the early detection of cancer and its mutations. For example, in December 2021, Thermo Fisher Scientific Inc., a US-based company specializing in oncology molecular diagnostics, obtained FDA approval for a Next-Generation Sequencing (NGS)-based companion diagnostic test designed for non-small cell lung cancer patients. This test aids medical professionals in determining the suitability of Janssen Biotech's targeted medication RYBREVANT (amivantamab-vmjw) for these patients.

Leading companies in the oncology molecular diagnostics market are directing their efforts toward innovative products, such as oncology liquid biopsy products, to enhance market revenues. Oncology liquid biopsy products serve as advanced diagnostic tools and tests facilitating the non-invasive detection and monitoring of cancer by analyzing various biomarkers and genetic material. In July 2022, BillionToOne Inc., a US-based biotechnology company specializing in molecular diagnostics and genetic testing, launched oncology liquid biopsy products, namely NorthStar Select and NorthStar Response. NorthStar Select is a comprehensive somatic mutation profiling panel for cancer, identifying actionable mutations with a significant limit of detection due to BillionToOne's proprietary molecular counting method, known as quantitative counting templates (QCTs). NorthStar Response is a tissue-neutral, methylation-based treatment response monitoring test, providing an accurate estimation of the burden of methylation circulating tumor DNA (ctDNA) using molecular counting technologies.

In September 2021, HealthCare Global Enterprises Limited, an India-based oncology care provider, acquired Oncology hospital labs and the clinical trial business from Strand Lifesciences. This acquisition enhances its in-house diagnostic and research capabilities, fostering greater awareness and adoption of cancer diagnostics. Strand Lifesciences is an India-based company specializing in oncology and technology.

Major companies operating in the oncology molecular diagnostics market report are F. Hoffmann-La Roche AG, Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthcare AG, Becton Dickinson and Company, Agilent Technologies Inc., HTG Molecular Diagnostics Inc., Hologic Inc., Illumina Inc., bioMérieux SA, Charles River Laboratories India Pvt. Ltd., Beckman Coulter Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., Qiagen N.V., Exact Sciences Corp., Bio-Techne Corporation, OPKO Health Inc., Myriad Genetics Inc., Guardant Health AMEA, Veracyte Inc., Adaptive Biotechnologies Corp., Foundation Medicine Inc., Pacific Biosciences of California Inc., NanoString Technologies lnc., TBG Diagnostics Limited, The Genetics of Cancer, Genomic Health Inc. North America was the largest region in the oncology molecular diagnostics market in 2023. Western Europe was the second largest region in the global oncology molecular diagnostics market report. The regions covered in the oncology molecular diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The primary products within the oncology molecular diagnostics market include instruments, reagents, and other related items. Instruments play a crucial role in cancer diagnosis, employing various technologies such as polymerase chain reaction (PCR), in-situ hybridization (ISH), isothermal nucleic acid amplification technology (INNAT), chips and microarrays, sequencing, mass spectrometry, transcription-mediated amplification (TMA), among others. These technologies find applications across diverse end-users, including hospitals, diagnostic centers, academic and research institutes, and other healthcare institutions.

The oncology molecular diagnostics market research report is one of a series of new reports that provides oncology molecular diagnostics market statistics, including oncology molecular diagnostics industry global market size, regional shares, competitors with a oncology molecular diagnostics market share, detailed oncology molecular diagnostics segments, market trends and opportunities, and any further data you may need to thrive in the oncology molecular diagnostics industry. This oncology molecular diagnostics research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The countries covered in the oncology molecular diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The oncology molecular diagnostics market includes revenues earned by oncology molecular diagnostics tools and kits. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.

Table of Contents

1. Executive Summary2. Oncology Molecular Diagnostics Market Characteristics3. Oncology Molecular Diagnostics Market Trends and Strategies
4. Oncology Molecular Diagnostics Market - Macro Economic Scenario
4.1. Impact of High Inflation on the Market
4.2. Ukraine-Russia War Impact on the Market
4.3. COVID-19 Impact on the Market
5. Global Oncology Molecular Diagnostics Market Size and Growth
5.1. Global Oncology Molecular Diagnostics Market Drivers and Restraints
5.1.1. Drivers of the Market
5.1.2. Restraints of the Market
5.2. Global Oncology Molecular Diagnostics Historic Market Size and Growth, 2018-2023, Value ($ Billion)
5.3. Global Oncology Molecular Diagnostics Forecast Market Size and Growth, 2023-2028, 2033F, Value ($ Billion)
6. Oncology Molecular Diagnostics Market Segmentation
6.1. Global Oncology Molecular Diagnostics Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Instruments
  • Reagents
  • Other Products
6.2. Global Oncology Molecular Diagnostics Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Polymerase Chain Reaction (PCR)
  • in-situ Hybridization (ISH)
  • Isothermic Nucleic Acid Amplification Technology (INNAT)
  • Chips & Microarrays
  • Sequencing
  • Mass Spectroscopy
  • Transcription Mediated Amplification (TMA)
  • Other Technologies
6.3. Global Oncology Molecular Diagnostics Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Diagnostic Centers
  • Academic & Research Institutes
  • Other End Users
7. Oncology Molecular Diagnostics Market Regional and Country Analysis
7.1. Global Oncology Molecular Diagnostics Market, Split by Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Oncology Molecular Diagnostics Market, Split by Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8. Asia-Pacific Oncology Molecular Diagnostics Market
8.1. Asia-Pacific Oncology Molecular Diagnostics Market Overview
Region Information, Impact of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Oncology Molecular Diagnostics Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Oncology Molecular Diagnostics Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Oncology Molecular Diagnostics Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9. China Oncology Molecular Diagnostics Market
9.1. China Oncology Molecular Diagnostics Market Overview
9.2. China Oncology Molecular Diagnostics Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Oncology Molecular Diagnostics Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Oncology Molecular Diagnostics Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10. India Oncology Molecular Diagnostics Market
10.1. India Oncology Molecular Diagnostics Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Oncology Molecular Diagnostics Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Oncology Molecular Diagnostics Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11. Japan Oncology Molecular Diagnostics Market
11.1. Japan Oncology Molecular Diagnostics Market Overview
11.2. Japan Oncology Molecular Diagnostics Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Oncology Molecular Diagnostics Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Oncology Molecular Diagnostics Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12. Australia Oncology Molecular Diagnostics Market
12.1. Australia Oncology Molecular Diagnostics Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Oncology Molecular Diagnostics Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Oncology Molecular Diagnostics Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13. Indonesia Oncology Molecular Diagnostics Market
13.1. Indonesia Oncology Molecular Diagnostics Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Oncology Molecular Diagnostics Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Oncology Molecular Diagnostics Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14. South Korea Oncology Molecular Diagnostics Market
14.1. South Korea Oncology Molecular Diagnostics Market Overview
14.2. South Korea Oncology Molecular Diagnostics Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Oncology Molecular Diagnostics Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Oncology Molecular Diagnostics Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15. Western Europe Oncology Molecular Diagnostics Market
15.1. Western Europe Oncology Molecular Diagnostics Market Overview
15.2. Western Europe Oncology Molecular Diagnostics Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Oncology Molecular Diagnostics Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Oncology Molecular Diagnostics Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16. UK Oncology Molecular Diagnostics Market
16.1. UK Oncology Molecular Diagnostics Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Oncology Molecular Diagnostics Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Oncology Molecular Diagnostics Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17. Germany Oncology Molecular Diagnostics Market
17.1. Germany Oncology Molecular Diagnostics Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Oncology Molecular Diagnostics Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Oncology Molecular Diagnostics Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18. France Oncology Molecular Diagnostics Market
18.1. France Oncology Molecular Diagnostics Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Oncology Molecular Diagnostics Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Oncology Molecular Diagnostics Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19. Italy Oncology Molecular Diagnostics Market
19.1. Italy Oncology Molecular Diagnostics Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Oncology Molecular Diagnostics Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Oncology Molecular Diagnostics Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20. Spain Oncology Molecular Diagnostics Market
20.1. Spain Oncology Molecular Diagnostics Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Oncology Molecular Diagnostics Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Oncology Molecular Diagnostics Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21. Eastern Europe Oncology Molecular Diagnostics Market
21.1. Eastern Europe Oncology Molecular Diagnostics Market Overview
21.2. Eastern Europe Oncology Molecular Diagnostics Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Oncology Molecular Diagnostics Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Oncology Molecular Diagnostics Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22. Russia Oncology Molecular Diagnostics Market
22.1. Russia Oncology Molecular Diagnostics Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Oncology Molecular Diagnostics Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Oncology Molecular Diagnostics Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23. North America Oncology Molecular Diagnostics Market
23.1. North America Oncology Molecular Diagnostics Market Overview
23.2. North America Oncology Molecular Diagnostics Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Oncology Molecular Diagnostics Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Oncology Molecular Diagnostics Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24. USA Oncology Molecular Diagnostics Market
24.1. USA Oncology Molecular Diagnostics Market Overview
24.2. USA Oncology Molecular Diagnostics Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Oncology Molecular Diagnostics Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Oncology Molecular Diagnostics Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25. Canada Oncology Molecular Diagnostics Market
25.1. Canada Oncology Molecular Diagnostics Market Overview
25.2. Canada Oncology Molecular Diagnostics Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Oncology Molecular Diagnostics Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Oncology Molecular Diagnostics Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26. South America Oncology Molecular Diagnostics Market
26.1. South America Oncology Molecular Diagnostics Market Overview
26.2. South America Oncology Molecular Diagnostics Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Oncology Molecular Diagnostics Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Oncology Molecular Diagnostics Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27. Brazil Oncology Molecular Diagnostics Market
27.1. Brazil Oncology Molecular Diagnostics Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Oncology Molecular Diagnostics Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Oncology Molecular Diagnostics Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28. Middle East Oncology Molecular Diagnostics Market
28.1. Middle East Oncology Molecular Diagnostics Market Overview
28.2. Middle East Oncology Molecular Diagnostics Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Oncology Molecular Diagnostics Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Oncology Molecular Diagnostics Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29. Africa Oncology Molecular Diagnostics Market
29.1. Africa Oncology Molecular Diagnostics Market Overview
29.2. Africa Oncology Molecular Diagnostics Market, Segmentation by Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Oncology Molecular Diagnostics Market, Segmentation by Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Oncology Molecular Diagnostics Market, Segmentation by End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
30. Oncology Molecular Diagnostics Market Competitive Landscape and Company Profiles
30.1. Oncology Molecular Diagnostics Market Competitive Landscape
30.2. Oncology Molecular Diagnostics Market Company Profiles
30.2.1. F. Hoffmann-La Roche AG
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. Bayer AG
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. Thermo Fisher Scientific Inc.
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. Abbott Laboratories
30.2.4.1. Overview
30.2.4.2. Products and Services
30.2.4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. Danaher Corporation
30.2.5.1. Overview
30.2.5.2. Products and Services
30.2.5.3. Strategy
30.2.5.4. Financial Performance
31. Oncology Molecular Diagnostics Market Other Major and Innovative Companies
31.1. Siemens Healthcare AG
31.2. Becton Dickinson and Company
31.3. Agilent Technologies Inc.
31.4. HTG Molecular Diagnostics Inc.
31.5. Hologic Inc.
31.6. Illumina Inc.
31.7. bioMérieux SA
31.8. Charles River Laboratories India Pvt. Ltd.
31.9. Beckman Coulter Inc.
31.10. Sysmex Corporation
31.11. Bio-Rad Laboratories Inc.
31.12. Qiagen N.V.
31.13. Exact Sciences Corp.
31.14. Bio-Techne Corporation
31.15. OPKO Health Inc.
32. Global Oncology Molecular Diagnostics Market Competitive Benchmarking33. Global Oncology Molecular Diagnostics Market Competitive Dashboard34. Key Mergers and Acquisitions in the Oncology Molecular Diagnostics Market
35. Oncology Molecular Diagnostics Market Future Outlook and Potential Analysis
35.1 Oncology Molecular Diagnostics Market in 2028 - Countries Offering Most New Opportunities
35.2 Oncology Molecular Diagnostics Market in 2028 - Segments Offering Most New Opportunities
35.3 Oncology Molecular Diagnostics Market in 2028 - Growth Strategies
35.3.1 Market Trend-based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic and Forecast Inflation Rates
36.4. Research Inquiries
36.5. About the Analyst
36.6. Copyright and Disclaimer

Executive Summary

Oncology Molecular Diagnostics Global Market Report 2024 provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on oncology molecular diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia-Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis.
  • Report will be updated with the latest data and delivered to you with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for oncology molecular diagnostics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? This report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
  • The impact of higher inflation in many countries and the resulting spike in interest rates.
  • The continued but declining impact of COVID-19 on supply chains and consumption patterns.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Report Scope

Markets Covered:
1) By Product: Instruments; Reagents; Other Products
2) By Technology: Polymerase Chain Reaction (PCR); In-situ Hybridization (ISH); Isothermic Nucleic Acid Amplification Technology (INNAT); Chips & Microarrays; Sequencing; Mass Spectroscopy; Transcription Mediated Amplification (TMA); Other Technologies
3) By End-user: Hospitals; Diagnostic Centers; Academic & Research Institutes; Other End-users

Key Companies Mentioned: F. Hoffmann-La Roche AG; Bayer AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita

Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes

Delivery Format: PDF, Word and Excel Data Dashboard

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • F. Hoffmann-La Roche AG
  • Bayer AG
  • Thermo Fisher Scientific Inc.
  • Abbott Laboratories
  • Danaher Corporation
  • Siemens Healthcare AG
  • Becton Dickinson and Company
  • Agilent Technologies Inc.
  • HTG Molecular Diagnostics Inc.
  • Hologic Inc.
  • Illumina Inc.
  • bioMérieux SA
  • Charles River Laboratories India Pvt. Ltd.
  • Beckman Coulter Inc.
  • Sysmex Corporation
  • Bio-Rad Laboratories Inc.
  • Qiagen N.V.
  • Exact Sciences Corp.
  • Bio-Techne Corporation
  • OPKO Health Inc.
  • Myriad Genetics Inc.
  • Guardant Health AMEA
  • Veracyte Inc.
  • Adaptive Biotechnologies Corp.
  • Foundation Medicine Inc.
  • Pacific Biosciences of California Inc.
  • NanoString Technologies lnc.
  • TBG Diagnostics Limited
  • The Genetics of Cancer
  • Genomic Health Inc.

Methodology

Loading
LOADING...

Table Information